Buying GLP-1 Weight Loss Medication Online: What You Should Know
GLP-1 receptor agonists have changed weight loss medicine. Medications like Wegovy, Zepbound, and Mounjaro produce the kind of results that were previously only achievable through bariatric surgery, with average weight reductions of 15 to 22% of body weight in clinical trials. But not every GLP-1 is the same, and not every patient needs the most aggressive option.
If your primary goal is weight loss and you do not have type 2 diabetes, Wegovy and Zepbound are the two medications with dedicated FDA approval for chronic weight management. Zepbound (tirzepatide) is the newer of the two and produced the highest weight loss numbers in head-to-head trials. Wegovy (semaglutide 2.4mg) has a longer track record and additional cardiovascular outcome data from the SELECT trial.
If you also have type 2 diabetes, Mounjaro and Ozempic are the most common choices because they are approved for diabetes and produce substantial weight loss as a secondary benefit. For patients who want to avoid injections entirely, Rybelsus offers oral semaglutide as a daily tablet, though the weight loss is more modest than the injectable forms.
Phentermine works differently. It is a stimulant-based appetite suppressant approved for short-term use (typically 12 weeks). Many clinicians use it as a bridge medication while patients titrate onto a GLP-1, or for patients who do not meet the criteria for GLP-1 therapy. It is not a long-term solution on its own, but it can be a useful tool in a structured weight loss plan.